Eledon Pharmaceuticals
ELDN
ELDN
29 hedge funds and large institutions have $16.5M invested in Eledon Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.04% less ownership
Funds ownership: 37.87% → 37.83% (-0.04%)
Holders
29
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$507K | |
| 2 | +$119K | |
| 3 | +$41.3K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$32.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29K |
Top Sellers
| 1 | -$220K | |
| 2 | -$132K | |
| 3 | -$18.5K | |
| 4 |
Two Sigma Advisers
New York
|
-$17.9K |
| 5 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$13.7K |